Relationship of MR-Derived Lactate, Mobile Lipids, and Relative Blood Volume for Gliomas in Vivo

References

1. ↵
   Allen M. Oxidative metabolism of brain. Prog Exp Tumor Res 1972;17:192–209

   PubMed
2. ↵
   Stone HB, Brown JM, Phillips TL, Sutherland RM. Oxygen in human tumors: correlations between methods of measurement and response to therapy—summary of a workshop held November 19–20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat Res 1993;136:422–434

   PubMedWeb of Science
3. ↵
   Evans SM, Koch CJ. Prognostic significance of tumor oxygenation in humans. Cancer Lett 2003;195:1–16

   CrossRefPubMedWeb of Science
4. ↵
   Usenius JP, Vainio P, Hernesniemi J, Kauppinen RA. Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro. J Neurochem 1994;63:1538–1543

   PubMedWeb of Science
5. Chang L, McBride D, Miller BL, et al. Localized in vivo 1H magnetic resonance spectroscopy and in vitro analyses of heterogeneous brain tumors. J Neuroimaging 1995;5:157–163

   PubMed
6. ↵
   Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84:449–458

   CrossRefPubMedWeb of Science
7. Nelson SJ, Vigneron DB, Dillon WP. Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI. NMR Biomed 1999;12:123–138

   CrossRefPubMed
8. Li X, Lu Y, Pirzkall A, McKnight TR, Nelson SJ. Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. J Magn Reson Imaging 2002;16:229–237

   CrossRefPubMedWeb of Science
9. ↵
   Kaminogo M, Ishimaru H, Morikawa M, et al. Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localized proton spectroscopy of brain. Neuroradiology 2001;43:353–363

   CrossRefPubMedWeb of Science
10. ↵
    Alger JR, Frank JA, Bizzi A, et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 1990;177:633–641

    PubMedWeb of Science
11. ↵
    Herholz K, Heindel W, Luyten PR, et al. In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann Neurol 1992;31:319–327

    CrossRefPubMedWeb of Science
12. ↵
    Remy C, Fouilhe N, Barba I, et al. Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets. Cancer Res 1997;57:407–414

    Abstract/FREE Full Text
13. ↵
    Kuesel AC, Sutherland GR, Halliday W, Smith ICP. 1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR Biomed 1994;7:149–155

    PubMed
14. ↵
    Cheng LL, Chang IW, Louis DN, Gonzalez RG. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res 1998;58:1825–1832

    Abstract/FREE Full Text
15. ↵
    Star-Lack J, Spielman D, Adalsteinsson E, Kurhanewicz J, Terris DJ, Vigneron DB. In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors. J Magn Reson 1998;133:243–254

    CrossRefPubMedWeb of Science
16. ↵
    Yetkin FZ, Mendelsohn D. Hypoxia imaging in brain tumors. Neuroimaging Clin N Am 2002;12:537–552

    CrossRefPubMedWeb of Science
17. ↵
    Rosen BR, Belliveau JW, Chien D, Perfusion imaging by nuclear magnetic resonance. Magn Reson Q 1989;5:263–281

    PubMed
18. ↵
    Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41–51

    PubMedWeb of Science
19. ↵
    Cha S, Johnson G, Wadghiri YZ, et al. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med 2003;49:848–855

    CrossRefPubMedWeb of Science
20. ↵
    Tran TK, Vigneron DB, Sailasuta N, et al. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn Reson Med 2000;43:23–33

    CrossRefPubMedWeb of Science
21. ↵
    Li X, Graves EE, Vigneron DB, Cha S, McKnight TR, Nelson SJ. Reliable estimate of lactate and lipid for newly-diagnosed gliomas patients using lactate-edited 3D 1H-MRSI with ellipsoidal k-space sampling. In: Proceedings of the 11^th ISMRM. Berkeley: International Society for Magnetic Resonance in Medicine;2003 :753
22. ↵
    Nelson SJ. Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med 2001;46:228–239

    CrossRefPubMedWeb of Science
23. ↵
    Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–798

    CrossRefPubMedWeb of Science
24. ↵
    Go KG, Kamman RL, Mooyaart EL, et al. Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography. Neuroradiology 1995;37:198–206

    PubMed
25. ↵
    Tien RD, Lai PH, Smith JS, Lazeyras F. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. AJNR Am J Neuroradiol 1996;167:201–209
26. ↵
    Garcia-Martin ML, Herigault G, Remy C, et al. Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites. Cancer Res 2001;61:6524–6531

    Abstract/FREE Full Text
27. ↵
    Terpstra M, High WB, Luo Y, de Graaf RA, Merkle H, Garwood M. Relationships among lactate concentration, blood flow and histopathologic profiles in rat C6 glioma. NMR Biomed 1996;9:185–194

    CrossRefPubMed
28. ↵
    Engelhard H, Groothuis D. In: Berger M, Wilson C, eds. The Gliomas. Philadelphia: W. B. Saunders;1999 :115–121
29. ↵
    Bental M, Deutsch C. Metabolic changes in activated T cells: an NMR study of human peripheral blood lymphocytes. Magn Reson Med 1993;29:317–26

    CrossRefPubMedWeb of Science
30. ↵
    Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998;171:1479–1486

    CrossRefPubMedWeb of Science
31. ↵
    Henry RG, Vigneron DB, Fischbein NJ, et al. Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 2000;21:357–366

    Abstract/FREE Full Text
32. ↵
    Folkman J. Tumor angiogenesis. Adv Cancer Res 1974;19:331–358

    PubMed
33. ↵
    Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, Semenza GL. Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 2000;88:2606–2618

    CrossRefPubMedWeb of Science
34. ↵
    Ljungkvist AS, Bussink J, Rijken PF, Kaanders JH, van der Kogel AJ, Denekamp J. Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2002;54:215–228

    PubMedWeb of Science
35. ↵
    Walenta S, Salameh A, Lyng H, et al. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol 1997;150:409–415

    PubMedWeb of Science
36. ↵
    Tarnawski R, Sokol M, Pieniazek P, et al. 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 2002;52:1271–1276

    CrossRefPubMedWeb of Science